Ophthalmologists recognize retinal vein occlusion (RVO), commonly called "eye stroke," as a serious disease and significant cause of blindness. Surprisingly, the magnitude of the problem had been ...

A population-based cohort study found that patients with retinal vein occlusion (RVO) 40 years and older had increased risk of cardiovascular disease CVD compared with patients who did not have RVO.

Covid-19 infection is linked to eye conditions called retinal vascular occlusions—blockages of blood vessels in the eye that can cause vision loss—according to a study published Thursday by JAMA ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved Vabysmo ...

There are many factors that can impact our eyesight, but one common source of vision loss centers on a blockage in the major vein in the eyeball, which prevents it from draining properly and damages ...

June 24, 2009 — On June 17, the US Food and Drug Administration (FDA) approved a dexamethasone 0.7-mg intravitreal implant (Ozurdex, Allergan, Inc) for the treatment of macular edema after branch ...

Background: Branch retinal vein occlusion is a frequent cause of visual loss with currently insufficient treatment options. We evaluate the effect of Bevacizumab (Avastin ®) treatment in patients with ...

Women filling a prescription for female hormone therapy (FHT), and presumably taking FHT, are not at increased risk of retinal artery or retinal vein occlusions. FHT, including oral contraceptive ...

Leuven, April 23, 2015 - ThromboGenics NV (Euronext Brussels:THR), an integrated biopharmaceutical company focused on developing and commercializing innovative medicines for the treatment of ...

– Additional U.S. label update across indications includes information on rare post-marketing reports of retinal vasculitis and/or retinal vascular occlusion; reporting rate is in line with other ...